BIOPHEN Heparin Anti-Xa (2 stages) - Replaced by A221005
Processing...

BIOPHEN Heparin Anti-Xa (2 stages) - Replaced by A221005

Code: A221010-USP
Manufacturer’s Part Number: 221010
Product size: Kit

Price: Discontinued

Qty
 

Product Description

This product has been updated and replaced with two products, A221005 (reagents) and AAR030K (buffer).

Chromogenic anti-Xa method for measuring homogeneously heparin in plasma (tested diluted 1:10) or in purified systems, using a two stage method. Offers a wide measurement range from 0 to 1 IU/mL for plasma, or from 0.005 to 0.10 IU/mL for purified systems and is appropriate for testing heparins for their anti-FXa activity. This assay is in compliance with USP Anti-FXa assay for unfractionated heparin.

Please see important notification letter from the manufacturer regarding the use of this product.

Product Characteristics

  • Total Assay Time: < 5 min
  • Detection Threshold: < 0.1 IU/mL
  • Dynamic Range: 0 to 1 IU/mL
  • Dynamic Range When Diluted: 0 to 0.1 IU/mL
  • Intra-Assay CV: < 3%
  • Inter-Assay CV: < 5%
  • Number of Tests (Manual Microplate Method): 2 x 100 Tests

Product Components

  • R1: 2 x 1 mL ATIII
  • R2: 2 x 1 mL FXa
  • R3: 2 x 5 mL FXa substrate (SXa-11)
  • R4: 4 x 25 mL Reaction buffer

Product Applications

For the measurement of anti-Xa Heparin activity in research applications.

This assay, using a predilution of Antithrombin and FXa reagents in R4 buffer, is in compliance with the USP Anti-Factor Xa assay for unfractionated heparin.

Please Note: Results obtained should be for research purposes only and not used for patient diagnosis or treatment.

Instructions For Use

Material Safety Data Sheet (MSDS)

Technical Data

Certificate of Analysis (COA)

Other Documents